APTA.ST
Price:
$0.982
Market Cap:
$16.98M
Aptahem AB (publ), a clinical stage biotechnology company, develops aptamer-based pharmaceuticals for the treatment of acute life-threatening conditions. Its principal pharmaceutical candidate is Apta-1, which is in preclinical stage to prevent mortality rate caused by organ and tissue damage in sepsis patients. The company has collaborations with various academic groups, including Consortium with Orebro University, Seattle Children's Research Institute, and University Health Network. Aptahem AB (publ) was incorporated in 2014 and is based in Malmö, Sweden.
Industry
Biotechnology
IPO Date
2015-04-17
Stock Exchange
STO
Ticker
APTA.ST
According to Aptahem AB (publ)’s latest financial reports and current stock price. The company's current PE Ratio is 16.37. This represents a change of -674.40% compared to the average of -2.85 of the last 4 quarters.
The mean historical PE Ratio of Aptahem AB (publ) over the last ten years is -6.04. The current 16.37 PE Ratio has changed -27203.30% with respect to the historical average. Over the past ten years (40 quarters), APTA.ST's PE Ratio was at its highest in in the June 2024 quarter at -0.72. The PE Ratio was at its lowest in in the September 2022 quarter at -10.98.
Average
-6.04
Median
-4.87
Minimum
-17.25
Maximum
-0.65
Discovering the peaks and valleys of Aptahem AB (publ) PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.17%
Maximum Annual PE Ratio = -0.65
Minimum Annual Increase = -88.40%
Minimum Annual PE Ratio = -17.25
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -2.06 | -1.10% |
| 2023 | -2.08 | -78.81% |
| 2022 | -9.82 | 158.77% |
| 2021 | -3.80 | -22.02% |
| 2020 | -4.87 | -40.87% |
| 2019 | -8.23 | 1.17% |
| 2018 | -0.65 | -88.40% |
| 2017 | -5.61 | -67.48% |
The current PE Ratio of Aptahem AB (publ) (APTA.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-4.65
5-year avg
-4.52
10-year avg
-6.04
Aptahem AB (publ)’s PE Ratio is greater than Fluicell AB (publ) (-1.81), greater than Stayble Therapeutics AB (publ) (-1.95), greater than Spermosens AB (-2.13), greater than 2cureX AB (publ) (-4.86), greater than Prostatype Genomics AB (publ) (-0.21), greater than Guard Therapeutics International AB (publ) (-0.24), greater than LIDDS AB (publ) (-1.69), greater than ODI Pharma AB (-5.18), greater than Quia Pharma AB (publ) (-0.05), greater than Chordate Medical Holding AB (publ) (-0.06),
| Company | PE Ratio | Market cap |
|---|---|---|
| -1.81 | $14.56M | |
| -1.95 | $16.38M | |
| -2.13 | $19.35M | |
| -4.86 | $23.85M | |
| -0.21 | $20.77M | |
| -0.24 | $28.03M | |
| -1.69 | $6.69M | |
| -5.18 | $30.98M | |
| -0.05 | $2.36M | |
| -0.06 | $1.49M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aptahem AB (publ) using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Aptahem AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Aptahem AB (publ)'s PE Ratio?
How is the PE Ratio calculated for Aptahem AB (publ) (APTA.ST)?
What is the highest PE Ratio for Aptahem AB (publ) (APTA.ST)?
What is the 3-year average PE Ratio for Aptahem AB (publ) (APTA.ST)?
What is the 5-year average PE Ratio for Aptahem AB (publ) (APTA.ST)?
How does the current PE Ratio for Aptahem AB (publ) (APTA.ST) compare to its historical average?